What is the best course of action for a patient with a history of surgically resected right adrenal lymphangioma and partially resected left paraspinal ganglioneuroma presenting with a solid mass on their right upper back?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Solid Mass on Right Upper Back in Patient with History of Adrenal Lymphangioma and Paraspinal Ganglioneuroma

This patient requires tissue diagnosis via core needle biopsy (preferred) or excisional biopsy to definitively characterize the new solid mass, given the history of partially resected ganglioneuroma which can recur or develop new lesions at distant sites. 1, 2

Immediate Diagnostic Approach

Tissue Biopsy is Essential

  • Core needle biopsy is the preferred initial diagnostic method for any new solid mass in this clinical context, as it provides tissue for histopathological and immunohistochemical analysis while being minimally invasive 1
  • If core biopsy is non-diagnostic or image-discordant with clinical suspicion, proceed directly to excisional biopsy 1
  • The three-month duration of this "knot" suggests a persistent lesion requiring definitive characterization rather than observation 1

Critical Pre-Biopsy Imaging

  • Obtain MRI of the upper back mass to assess size, margins (well-defined vs irregular), homogeneity, and relationship to adjacent structures 1, 2
  • Homogeneous density, oval shape, and well-defined borders are characteristic radiologic features of ganglioneuroma, but cannot exclude other diagnoses 2
  • MRI more clearly documents local invasion and soft tissue characteristics than CT 1

Differential Diagnosis Considerations

Ganglioneuroma Recurrence or New Primary

  • Ganglioneuromas can occur at multiple sites along the sympathetic chain, including subcutaneous locations 2, 3
  • The patient's history of partially resected left paraspinal ganglioneuroma is particularly concerning, as incomplete resection increases risk of local recurrence or development of additional lesions 4, 5
  • Ganglioneuromas are benign but can be metastatic or develop at multiple sites, requiring complete surgical excision when feasible 5, 2
  • These tumors consist of mature ganglion cells and nerve fibers, with positive S-100 immunohistochemistry 2, 3

Other Soft Tissue Lesions

  • Lipoma or atypical lipomatous tumor should be considered, though the description as "solid" makes simple lipoma less likely 1
  • Desmoid fibromatosis or other borderline soft tissue tumors are possible 1
  • Soft tissue sarcoma must be excluded, particularly given the subcutaneous location 1

Definitive Management Algorithm

If Biopsy Confirms Benign Ganglioneuroma

  • Complete surgical excision is the treatment of choice and is curative 4, 2
  • Surgical approach should achieve en bloc resection with preservation of adjacent neurovascular structures 1, 4
  • The tumor size and location will determine whether single-stage or staged resection is appropriate 4
  • Mean hospital stay for ganglioneuroma excision is approximately 15-16 days 2

If Biopsy Shows Atypical or Malignant Features

  • Refer to sarcoma multidisciplinary team for treatment planning 1
  • Surgical resection with appropriate margins based on histologic grade 1
  • Consider adjuvant radiotherapy for high-grade lesions with concerning features 1

Post-Operative Surveillance

Mandatory Long-Term Follow-Up

  • Close follow-up after surgery is mandatory for ganglioneuroma, as recurrence can occur even after complete resection 4, 2
  • Clinical examination every 6-12 months for at least 2 years, then annually for up to 5 years 2
  • Mean follow-up duration in ganglioneuroma series is 96 months (range 5-180 months) 2
  • Imaging should be performed if new masses develop or symptoms arise 2

Monitoring the Partially Resected Paraspinal Lesion

  • Continue surveillance of the known partially resected left paraspinal ganglioneuroma with periodic MRI 4, 5
  • Any growth >5 mm/year warrants consideration of completion resection 6

Critical Pitfalls to Avoid

  • Do not observe this mass without tissue diagnosis - the three-month duration and solid character mandate histopathological evaluation 1
  • Do not assume this is simply a lipoma or benign cyst without biopsy confirmation, given the patient's history of neural crest tumors 2, 3
  • Do not perform inadequate excision if ganglioneuroma is confirmed - incomplete resection leads to recurrence and potential need for more extensive re-operation 4, 5
  • Do not discharge from follow-up after excision - ganglioneuromas require long-term surveillance even after complete resection 4, 2
  • Avoid adrenal biopsy protocols for this superficial back mass - this is a different clinical scenario than adrenal incidentaloma management 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ganglioneuroma in unusual sites: clinical, radiologic and pathological features.

International journal of clinical and experimental pathology, 2018

Research

Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2002

Guideline

Adrenal Nodules Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.